EBR Systems (ASX:EBR) signed a purchasing agreement with HCA Healthcare, marking a key step in the commercial rollout of its WiSE cardiac resynchronization therapy system, according to a Wednesday Australian bourse filing.
The agreement facilitates wider deployment by simplifying procurement and contracting across HCA's hospital network, making it easier for clinicians and administrators to access the system, per the filing.
The company already operates at several HCA sites in Texas, and the partnership is expected to accelerate adoption and US commercial expansion, the filing added.
The company's shares rose 10% in recent Wednesday trade.